메뉴 건너뛰기




Volumn 6, Issue 1, 2013, Pages 49-54

Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors

Author keywords

Monoclonal antibody; Neuroendocrine tumor; Pancreatic tumor; Somatostatin

Indexed keywords

DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 5;

EID: 84870411759     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (21)
  • 1
    • 6044266281 scopus 로고    scopus 로고
    • Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment
    • Reubi JC. Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 2004; 80 Suppl 1: 51-56.
    • (2004) Neuroendocrinology , vol.80 , Issue.SUPPL 1 , pp. 51-56
    • Reubi, J.C.1
  • 2
    • 69749113601 scopus 로고    scopus 로고
    • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification
    • Kloppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M, Rindi G and Plockinger U. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90: 162-166.
    • (2009) Neuroendocrinology , vol.90 , pp. 162-166
    • Kloppel, G.1    Couvelard, A.2    Perren, A.3    Komminoth, P.4    McNicol, A.M.5    Nilsson, O.6    Scarpa, A.7    Scoazec, J.Y.8    Wiedenmann, B.9    Papotti, M.10    Rindi, G.11    Plockinger, U.12
  • 4
    • 34547877609 scopus 로고    scopus 로고
    • Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view
    • Prasad V, Fetscher S and Baum RP. Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view. J Pharm Pharm Sci 2007; 10: 321s-337s.
    • (2007) J Pharm Pharm Sci , vol.10
    • Prasad, V.1    Fetscher, S.2    Baum, R.P.3
  • 5
    • 57249095880 scopus 로고    scopus 로고
    • Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT
    • Miederer M, Seidl S, Buck A, Scheidhauer K, Wester HJ, Schwaiger M and Perren A. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 2009; 36: 48-52.
    • (2009) Eur J Nucl Med Mol Imaging , vol.36 , pp. 48-52
    • Miederer, M.1    Seidl, S.2    Buck, A.3    Scheidhauer, K.4    Wester, H.J.5    Schwaiger, M.6    Perren, A.7
  • 6
    • 57349142534 scopus 로고    scopus 로고
    • Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1
    • Fischer T, Doll C, Jacobs S, Kolodziej A, Stumm R and Schulz S. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab 2008; 93: 4519-4524.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 4519-4524
    • Fischer, T.1    Doll, C.2    Jacobs, S.3    Kolodziej, A.4    Stumm, R.5    Schulz, S.6
  • 7
    • 81355123315 scopus 로고    scopus 로고
    • Reassessment of sst(5) Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4
    • Lupp A, Hunder A, Petrich A, Nagel F, Doll C and Schulz S. Reassessment of sst(5) Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4. Neuroendocrinology 2011; 94(3): 255-64.
    • (2011) Neuroendocrinology , vol.94 , Issue.3 , pp. 255-264
    • Lupp, A.1    Hunder, A.2    Petrich, A.3    Nagel, F.4    Doll, C.5    Schulz, S.6
  • 11
    • 42749095844 scopus 로고    scopus 로고
    • Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001)
    • Schmid HA. Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001). Ann Endocrinol (Paris) 2008; 69: 162-163.
    • (2008) Ann Endocrinol (Paris) , vol.69 , pp. 162-163
    • Schmid, H.A.1
  • 12
    • 43549111835 scopus 로고    scopus 로고
    • Pasireotide (SOM230): development, mechanism of action and potential applications
    • Schmid HA. Pasireotide (SOM230): development, mechanism of action and potential applications. Mol Cell Endocrinol 2008; 286: 69-74.
    • (2008) Mol Cell Endocrinol , vol.286 , pp. 69-74
    • Schmid, H.A.1
  • 13
    • 83455211387 scopus 로고    scopus 로고
    • Effects of somatostatin analogs on glucose homeostasis in rats
    • Schmid HA and Brueggen J. Effects of somatostatin analogs on glucose homeostasis in rats. J Endocrinol 2012 Jan; 212: 49-60.
    • (2012) J Endocrinol , vol.212 , pp. 49-60
    • Schmid, H.A.1    Brueggen, J.2
  • 16
    • 40849118727 scopus 로고    scopus 로고
    • Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide
    • Takei M, Suzuki M, Kajiya H, Ishii Y, Tahara S, Miyakoshi T, Egashira N, Takekoshi S, Sanno N, Teramoto A and Osamura RY. Immunohistochemical detection of somatostatin receptor (SSTR) subtypes 2A and 5 in pituitary adenoma from acromegalic patients: good correlation with preoperative response to octreotide. Endocr Pathol 2007; 18: 208-216.
    • (2007) Endocr Pathol , vol.18 , pp. 208-216
    • Takei, M.1    Suzuki, M.2    Kajiya, H.3    Ishii, Y.4    Tahara, S.5    Miyakoshi, T.6    Egashira, N.7    Takekoshi, S.8    Sanno, N.9    Teramoto, A.10    Osamura, R.Y.11
  • 17
    • 0036135375 scopus 로고    scopus 로고
    • Identification of somatostatin receptor subtypes 1 2A 3 and 5 in neuroendocrine tumours with subtype specific antibodies
    • Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y and Arnold R. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 2002; 50: 52-60.
    • (2002) Gut , vol.50 , pp. 52-60
    • Kulaksiz, H.1    Eissele, R.2    Rossler, D.3    Schulz, S.4    Hollt, V.5    Cetin, Y.6    Arnold, R.7
  • 18
    • 0036271475 scopus 로고    scopus 로고
    • Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
    • Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, Schindler M, Cole SL and Bussolati G. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002; 440: 461-475.
    • (2002) Virchows Arch , vol.440 , pp. 461-475
    • Papotti, M.1    Bongiovanni, M.2    Volante, M.3    Allia, E.4    Landolfi, S.5    Helboe, L.6    Schindler, M.7    Cole, S.L.8    Bussolati, G.9
  • 19
    • 0035726431 scopus 로고    scopus 로고
    • Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
    • Papotti M, Kumar U, Volante M, Pecchioni C and Patel YC. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Clin Endocrinol (Oxf) 2001; 54: 641-649.
    • (2001) Clin Endocrinol (Oxf) , vol.54 , pp. 641-649
    • Papotti, M.1    Kumar, U.2    Volante, M.3    Pecchioni, C.4    Patel, Y.C.5
  • 20
    • 0042854927 scopus 로고    scopus 로고
    • Peptide receptors as molecular targets for cancer diagnosis and therapy
    • Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003; 24: 389-427.
    • (2003) Endocr Rev , vol.24 , pp. 389-427
    • Reubi, J.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.